Literature DB >> 12470520

Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles.

C Yding Andersen1.   

Abstract

FSH exists as a family of isohormones exhibiting distinct oligosaccharide structures, and the released FSH isoform mixtures change during the follicular phase of the menstrual cycle. In addition, the pulsatile release of gonadotrophins seems to expose follicles to bursts of more less-acidic FSH isoforms and the follicle is likely to be exposed to an almost ever changing composition of FSH isoforms. The different isoforms causes a number of different and divergent biological effects. FSH promotes oocyte maturation, and 5-10 IU/l of less-acidic FSH isoforms are sufficient to induce oocyte maturation in vitro. Exposure of cumulus-oocyte complexes to less-acidic FSH isoforms in a pulse-like fashion results in a rapid pattern of cAMP accumulation exceeding that seen with acidic isoforms, which appear to sustain lower but more constant cAMP production. The presence of particularly less-acidic isoforms for a period exceeding 30 min causes an attenuated cAMP response. In conclusion, it appears that pulsatile and intermittent release of less-acidic/short-living FSH isoforms is sufficient to induce biological responses, while allowing the granulosa cells to regain responsiveness to further FSH stimulation. Together with the interpulse release of more acidic isoforms, overall FSH secretion seems to ensure proper follicular maturation resulting in the release of developmentally competent oocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470520     DOI: 10.1016/s1472-6483(10)61826-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  20 in total

1.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

2.  Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: clinical and biochemical (cumulus cell gene expression) aspects.

Authors:  Timur Gurgan; Debbie Montjean; Aygul Demirol; Yves J R Menezo
Journal:  J Assist Reprod Genet       Date:  2014-03-18       Impact factor: 3.412

3.  GnRH triggering may improve euploidy and live birth rate in hyper-responders: a retrospective cohort study.

Authors:  Justin Tan; Chen Jing; Lisa Zhang; Jasmine Lo; Arohumam Kan; Gary Nakhuda
Journal:  J Assist Reprod Genet       Date:  2020-06-13       Impact factor: 3.412

4.  Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Anuja Dokras
Journal:  Fertil Steril       Date:  2014-11-06       Impact factor: 7.329

Review 5.  Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso
Journal:  Mol Cell Endocrinol       Date:  2019-11-02       Impact factor: 4.102

Review 6.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09

Review 7.  Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles.

Authors:  Engin Türkgeldi; Lale Türkgeldi; Ayşe Seyhan; Barış Ata
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

8.  Does the repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome improve in vitro fertilization cycles outcome? A clinical trial study.

Authors:  Abbas Aflatoonian; Fatemeh Haghighi; Masrooreh Hoseini; Saeid Haghdani
Journal:  Int J Reprod Biomed       Date:  2020-07-22

9.  Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.

Authors:  Antonio Requena; María Cruz; Francisco J Ruiz; Juan A García-Velasco
Journal:  Reprod Biol Endocrinol       Date:  2014-01-29       Impact factor: 5.211

10.  In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f).

Authors:  Renato Mastrangeli; Abhijeet Satwekar; Francesca Cutillo; Cinzia Ciampolillo; Wolf Palinsky; Salvatore Longobardi
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.